These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 29806132

  • 1. An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in β-thalassemia major patients: A double-blind randomized controlled clinical trial.
    Mohammadi E, Tamaddoni A, Qujeq D, Nasseri E, Zayeri F, Zand H, Gholami M, Mir SM.
    Phytother Res; 2018 Sep; 32(9):1828-1835. PubMed ID: 29806132
    [Abstract] [Full Text] [Related]

  • 2. The Effect of Curcumin on Iron Overload in Patients with Beta-Thalassemia Intermedia.
    Saeidnia M, Fazeli P, Erfani M, Nowrouzi-Sohrabi P, Tamaddon G, Karimi M.
    Clin Lab; 2022 Mar 01; 68(3):. PubMed ID: 35254032
    [Abstract] [Full Text] [Related]

  • 3. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
    Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M.
    Eur J Haematol; 2013 Mar 01; 90(3):202-9. PubMed ID: 23278124
    [Abstract] [Full Text] [Related]

  • 4. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
    Koonyosying P, Kongkarnka S, Uthaipibull C, Svasti S, Fucharoen S, Srichairatanakool S.
    Biomed Pharmacother; 2018 Dec 01; 108():1694-1702. PubMed ID: 30372872
    [Abstract] [Full Text] [Related]

  • 5. Suppression of Growth Differentiation Factor 15 Gene Expression by Curcumin in Patients with Beta-Thalassemia Intermedia.
    Saeidnia M, Ghaderi A, Erfani M, Nowrouzi-Sohrabi P, Shokri M, Tamaddon G, Karimi M, Babashahi M.
    Clin Lab; 2024 Jan 01; 70(1):. PubMed ID: 38213217
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB, Cappellini MD, Kattamis A, Viprakasit V, Musallam KM, Zhu Z, Taher AT.
    Br J Haematol; 2017 Jan 01; 176(2):288-299. PubMed ID: 27917462
    [Abstract] [Full Text] [Related]

  • 10. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, Kobayashi Y, Iwasa M, Watanabe S, Adachi Y, Kaito M.
    Mol Med; 2007 Jan 01; 13(1-2):97-104. PubMed ID: 17515961
    [Abstract] [Full Text] [Related]

  • 11. Correlation between plasma biochemical parameters and cardio-hepatic iron deposition in thalassemia major patients.
    Saadatifar H, Mard-Soltani M, Niayeshfar A, Shakerian N, Pouriamehr S, Alinezhad Dezfuli D, Khalili S, Saadatifar S, Mashhadi SM.
    Scand J Clin Lab Invest; 2024 Jul 01; 84(4):245-251. PubMed ID: 38953608
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Benefits of Curcumin Supplementation on Antioxidant Status in β-Thalassemia Major Patients: A Double-Blind Randomized Controlled Clinical Trial.
    Nasseri E, Mohammadi E, Tamaddoni A, Qujeq D, Zayeri F, Zand H.
    Ann Nutr Metab; 2017 Jul 01; 71(3-4):136-144. PubMed ID: 28881347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Consumption of a green tea extract-curcumin drink decreases blood urea nitrogen and redox iron in β-thalassemia patients.
    Koonyosying P, Tantiworawit A, Hantrakool S, Utama-Ang N, Cresswell M, Fucharoen S, Porter JB, Srichairatanakool S.
    Food Funct; 2020 Jan 29; 11(1):932-943. PubMed ID: 31950948
    [Abstract] [Full Text] [Related]

  • 16. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E, Ryan JD, Russell J, Coughlan B, Tjalsma H, Swinkels DW, Stewart S, Crowe JP.
    Acta Haematol; 2015 Jan 29; 133(2):155-61. PubMed ID: 25277871
    [Abstract] [Full Text] [Related]

  • 17. Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major.
    Zaman BA, Rasool SO, Merza MA, Abdulah DM.
    Transfus Clin Biol; 2022 May 29; 29(2):153-160. PubMed ID: 34856399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N, Tantiworawit A, Phrommintikul A, Saekho S, Srichairattanakool S, Chattipakorn N.
    Hemoglobin; 2015 May 29; 39(4):281-6. PubMed ID: 26029793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.